Kane Biotech is THE Biofilm Company, engaged in the research, development, and commercialization of technologies that break up biofilms and destroy bacteria.
Biofilms may be an uncommon word, but they impact our lives and health in many ways – including keeping us sick. A biofilm is a glue-like substance excreted by bacteria & fungi to attach to surfaces that “houses”, protects, & allows bacteria to thrive in hostile environments.
@KaneBio announced their partnership in Nov. with ProgenaCare to launch its revyve™ Antimicrobial #Wound Gel. “We are excited to share this cutting-edge product and the new revyve™ brand with the larger wound care community,” stated Howard Walthall, CEO of ProgenaCare.
Kane Biotech has filed a patent on its revyve™ Antimicrobial Wound Gel Spray, a follow-on product to its FDA 510(k) cleared revyve™ Antimicrobial Wound Gel. Kane is in the final stages of development of this product which is still pending FDA clearance. #biofilm#medical
Kane Biotech's CSO, Greg Schultz, PhD, did an excellent job at the #BoswickSymposium presenting revyve™ Antimicrobial Wound Gel Spray, which @KaneBio has filed a #patent on and is a follow-on product to its FDA 510(k) cleared revyve™ Antimicrobial #Wound Gel.
The Estimated Costs of Wounds in the USA and Its States: The International Wound Journal recently published an editorial showing what the USA and its individual states could be spending on managing wounds.
onlinelibrary.wiley.com/doi/…#woundcare#wounds#costs#IWJ#USA
Kane Biotech announces that it has filed a patent on its revyve™ Antimicrobial Wound Gel Spray, a follow-on product to its FDA 510(k) cleared revyve™ Antimicrobial Wound Gel, and will be introducing it at the Boswick Burn and Wound Care Symposium. bit.ly/48UsxhP
Kane is at the forefront of where innovation and discovery are created. Kane's labs are located in the University of Manitoba Smartpark Innovation Hub, &include 2 independent analytical laboratories & 3 independent microbiology suites.
Take a 3D lab tour: bit.ly/3SBx6b7
@KaneBio announced that on February 20, 2024, the Company will hold a special meeting of its shareholders to consider the election of Dr. Robert Huizinga as an additional director of the Company. Learn more: bit.ly/3Sqjob2
revyve™ Antimicrobial Wound Gel developed by @KaneBio is indicated for the use on:
*Partial and full thickness wounds
*Leg #ulcers
*Large surface area #wounds
*Pressure ulcers
*#Surgical incisions
*1st and 2nd degree #burns
*#Diabetic foot ulcers
Visit: revyvegel.com
Did you know? Keeping you sick is the ultimate goal of #biofilm. Biofilms make bacteria up to 1,000 times more resistant to #antibiotics and #antimicrobials, protecting the #bacteria which then affects the immune system. Learn more: kanebiotech.com